First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

527 Reviews

Credit Rating - ENTERPRISE THERAPEUTICS HOLDINGS LIMITED

ANALYSIS
Credit Risk Update: ENTERPRISE THERAPEUTICS HOLDINGS LIMITED, SUSSEX INNOVATION CENTRE SCIENCE PARK SQUARE, FALMER, BRIGHTON, BN1 9SB. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 December 2023. The company was incorporated on 9 September 2020.

The accounts next due date is 30 September 2025. There are no mortgages.

The above was based on public record information as at 5 November 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 12868901
Date Incorporated: 9 September 2020
Date Latest Accounts: 31 December 2023
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 12868901
Annual Return: Unknown
Registered Office: SUSSEX INNOVATION CENTRE SCIENCE PARK SQUARE, FALMER, BRIGHTON, BN1 9SB
SIC Code and Operations: 96090
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

ENTERPRISE THERAPEUTICS HOLDINGS LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 15 November 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
09022750 ENTERPRISE THERAPEUTICS LTD Active
08105584 ENTERPRISE TO GROW LTD Dissolved
13305673 ENTERPRISE TRADERS LTD Active
10049533 ENTERPRISE TRADING INVESTMENTS LIMITED Dissolved
OE020325 ENTERPRISE TRADING LIMITED Active

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd